Replies to post #40989 on Biotech Values

[poorgradstudent]

>comment on ENCY/Thelin approval not likely pending another trial.<

I get good inside dirt on many of the cardiovascular drugs. In addition, I get very reliable accounts of "real world" drug use and use trends, rather than the pie-in-the-sky expectations that I read about elsewhere. Sometimes putting those two sets of data together makes certain interpretations easy enough for even a dummy like me.